Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 80830

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 14, 2018
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Mckesson Corporation

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977 Dist. By: McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51

D-1172-2018
Recall number
D-1172-2018
Initiated
August 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
Mckesson Corporation
Quantity
1531 cartons

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Supterpotent Drug

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Supterpotent Drug

Code information

Lot #: 0116158 Exp. 4/30/19; 0113903, 0113902, 0113901, Exp. 8/31/18

Distribution pattern

Nationwide within the United States